Emerging treatments for post-transplantation diabetes mellitus
Crossref DOI link: https://doi.org/10.1038/nrneph.2015.59
Published Online: 2015-04-28
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jenssen, Trond
Hartmann, Anders
Text and Data Mining valid from 2015-04-28
Article History
First Online: 28 April 2015
Competing interests
: T.J. has received lecture honoraria from AstraZeneca, Novartis, Sanofi, and Merck Sharp & Dohme. A.H. declares no competing interests.